
This was seconday analysis of data from Daily co-trimoxazole prophylaxis to prevent mortality in children with complicated severe acute malnutrition: a multicentre, double-blind, randomized placebo-controlled trial ((ClinicalTrials.gov ID NCT00934492).
The aim of this secondary analysis was to investigate the associations of clinically diagnosed rickets at study enrolment with anthropometric recovery and life‐threatening events during 1 year following inpatient treatment for complicated SAM. The main outcomes were episodes of life‐threatening events and anthropometry (MUAC, weight, length/height, and head circumference) during the course of the primary trial of 12 months. Life‐threatening events were defined as all‐cause mortality or all hospital readmissions. Study participants data were collected at baseline and during one year follow-up.
Access to datasets is restricted as it contains sensitive information on participants. Accompanying documentation is available under open access. For more detailed information beyond the metadata and documentation provided, there is a process of managed access requiring submission of a request form for consideration by our Data Governance Committee ( kemri-wellcome.org )